Literature DB >> 29894993

Transbronchial Lung Cryobiopsy in Interstitial Lung Diseases: Best Practice.

Sara Colella1, Maik Haentschel2, Pallav Shah3,4,5, Venerino Poletti6,7, Jürgen Hetzel2.   

Abstract

The lung biopsy in interstitial lung disease (ILD) represents an important diagnostic step when the clinical and radiological data are insufficient for a firm diagnosis. A growing body of evidence suggests the utility of transbronchial lung cryobiopsy (TBLC) in the diagnostic algorithm of ILD as it allows, compared to transbronchial lung biopsy with conventional forceps, a better identification of complex histological patterns - such as usual interstitial pneumonia - and can provide information which has a clinical impact on the multidisciplinary discussion similar to that provided by surgical lung biopsy. Performed correctly, it appears to have a better safety profile than surgery. The decision to perform a lung biopsy should be a multidisciplinary decision process where it is felt that there is sufficient diagnostic doubt after a careful clinical evaluation including review of the computed tomograms of the thorax. The presence of severe pulmonary hypertension (> 50 mm Hg), poor lung function (FVC < 50%), or dismissed gas transfer (DLCO of < 35%) are considered relative contraindications for TBLC. Anticoagulants and antiplatelet drugs should be discontinued for the minimum period required for the specific drugs. The greatest consideration should be given to ensure the biopsy is performed safely and we recommend the use of either an endotracheal tube or rigid bronchoscopy. Deep sedation or general anesthesia allow better control of the procedure and a better patient experience. Prophylactic balloon blockers should be used to tamponade any bleeding and also to prevent overspill of blood from the segment that is being sampled. The procedure should be performed under fluoroscopy to ensure that samples are ideally obtained about 10 mm from the pleural edge. The cryoprobe is activated for about 5 s for the first biopsy and then adjusted according to the sample size obtained. With a careful standardized approach it is possible to obtain good-quality lung specimens for diagnosis in a safe manner.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Bronchoscopy; Diffuse lung disease; Idiopathic pulmonary fibrosis; Interstitial lung disease; Transbronchial lung cryobiopsy

Mesh:

Year:  2018        PMID: 29894993     DOI: 10.1159/000488910

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  19 in total

1.  Novel technique to prevent central airway blood flooding during transbronchial cryobiopsy.

Authors:  Masahide Oki; Hideo Saka
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

2.  Transbronchial cryobiopsy: an effective tool in the diagnosis of lymphoproliferative disorders of the lung.

Authors:  Rita Bianchi; Alessandra Dubini; Silvia Asioli; Claudia Ravaglia; Sara Tomassetti; Silvia Puglisi; Sara Piciucchi; Christian Gurioli; Carlo Gurioli; Roberto Fiocca; Venerino Poletti
Journal:  ERJ Open Res       Date:  2020-07-27

3.  Successful management of isolated pulmonary Langerhans cell histiocytosis in a 50-year-old man with early diagnosis using transbronchial cryobiopsy: A case report.

Authors:  Yan-Mei Feng; Yi-Shi Li; You-Lun Li; Pu Wang; Rui Guo
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

4.  Idiopathic pulmonary fibrosis: prognostic impact of histologic honeycombing in transbronchial lung cryobiopsy.

Authors:  Claudia Ravaglia; Marcello Bosi; Athol U Wells; Carlo Gurioli; Christian Gurioli; Alessandra Dubini; Sara Piciucchi; Silvia Puglisi; Susanna Mascetti; Antonella Arcadu; Sara Tomassetti; Venerino Poletti
Journal:  Multidiscip Respir Med       Date:  2019-02-08

5.  Diagnostic yield and safety of transbronchial cryobiopsy in sarcoidosis.

Authors:  Maria Jacob; Hélder Novais Bastos; Patrícia Caetano Mota; Natália Melo; Rui Cunha; José Miguel Pereira; Susana Guimarães; Conceição Souto Moura; António Morais
Journal:  ERJ Open Res       Date:  2019-10-21

6.  Transbronchial Lung Cryobiopsy in Diffuse Interstitial Lung Diseases . . . Bent but Not Broken.

Authors:  Ritesh Agarwal; Sahajal Dhooria; Inderpaul S Sehgal; Ravindra Mehta; Vallandaraman Pattabhiraman; Ashutosh N Aggarwal; Amanjit Bal; Arjun Srinivasan; Karan Madan; Anant Mohan; Prashant Chhajed; Rajiv Goyal; Jayachandra Akkaraju; Dharmesh Patel
Journal:  Am J Respir Crit Care Med       Date:  2019-10-01       Impact factor: 21.405

7.  The First Case of L. pseudomesenteroides Pulmonary Infection and Literature Review.

Authors:  Liwan Dai; Yishi Li; Xiaobing Zhang; Ming Ding; Shuliang Guo
Journal:  Case Rep Pulmonol       Date:  2020-11-17

8.  The Application of Transbronchial Lung Cryobiopsy and Uniportal and Tubeless Video-Assisted Thoracic Surgery in the Multidisciplinary Diagnosis of Interstitial Lung disease-A Real-World Prospective Study.

Authors:  Qian Han; Xiaobo Chen; Xin Xu; Weiping Qian; Gui Zhao; Mengmeng Mao; Bingpeng Guo; Shu Xia; Guilin Peng; Jianxing He; Yingying Gu; Shiyue Li; Qun Luo
Journal:  Front Mol Biosci       Date:  2021-06-16

9.  The significance of multidisciplinary classifications based on transbronchial pathology in possible idiopathic interstitial pneumonias.

Authors:  Weixue Wang; Jian Xu; Chunfang Liu; Ruie Feng; Junjun Zhao; Na Gao; Ling Jiang; Xiaolin Zhang; Xue Han; Lina Ren; Xiaohui Zhao; Yuan Liu
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

10.  Lung Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: A Series Contribution to a Debated Procedure.

Authors:  Sergio Harari; Francesca Cereda; Federico Pane; Alberto Cavazza; Nikolaos Papanikolaou; Giuseppe Pelosi; Monica Scarioni; Elisabetta Uslenghi; Maurizio Zompatori; Antonella Caminati
Journal:  Medicina (Kaunas)       Date:  2019-09-19       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.